Patients with sporadic and familial amyotrophic lateral sclerosis found value in genetic testing
- PMID: 29266834
- PMCID: PMC5902388
- DOI: 10.1002/mgg3.360
Patients with sporadic and familial amyotrophic lateral sclerosis found value in genetic testing
Abstract
Background: Amyotrophic lateral sclerosis (ALS) is increasingly recognized as a genetic disease. There is no consensus, however, as to the role of genetic testing in the care of the ALS patient.
Methods: We conducted a survey to study patient access, attitudes, and experience with ALS genetic testing among patients enrolled in a US ALS registry.
Results: Among 449 survey respondents, 156 (34.7%) were offered testing and 105 of 156 (67.3%) completed testing. The majority of respondents with familial ALS (fALS) (31/45, 68.9%) were offered testing, while a minority of respondents with sporadic ALS (sALS) (111/404, 27.5%) were offered testing (p = .00001). Comparison of mean test experience scores between groups revealed that respondents with fALS were no more likely to report a favorable experience with genetic testing than those with sALS (p = .51). Respondents who saw a genetic counselor did not have significantly different test experience scores, compared to those who did not (p = .14). In addition, no differences in test experience scores were observed between those who received positive or negative genetic test results (p = .98).
Conclusion: These data indicate that patients with ALS found value in clinical genetic testing.
Keywords: access to care; amyotrophic lateral sclerosis genetics; genetic counseling; genetic testing; patient attitudes.
© 2017 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
References
-
- Andersen, P. M. , Abrahams, S. , Borasio, G. D. , de Carvalho, M. , Chio, A. , Van Damme, P. , … Weber, M. (2012). EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force. EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. European Journal of Neurology, 3, 360–375. https://doi.org/10.1111/j.1468-1331.2011.03501.x - DOI - PubMed
-
- Arthur, K. C. , Calvo, A. , Price, T. R. , Geiger, J. T. , Chiò, A. , & Traynor, B. J. (2016). Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nature Communications, 7, 12408 https://doi.org/10.1038/ncomms12408 - DOI - PMC - PubMed
-
- Byrne, S. , Elamin, M. , Bede, P. , & Hardiman, O. (2012). Absence of consensus in diagnostic criteria for familial neurodegenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry, 83(4), 365–367. https://doi.org/10.1136/jnnp-2011-301530 - DOI - PubMed
-
- Chio, A , Battistini, S , Calvo, A , Caponnetto, C , Conforti, FL , Corbo, M , … Surbone, A. (2014). Genetic counselling in ALS: Facts, uncertainties and clinical suggestions. Journal of Neurology, Neurosurger and Psychiatry, 85(5), 478–485. https://doi.org/10.1136/jnnp-2013-305546 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
